Assignee
GENOIMMUNE THERAPEUTICS CO LTD
CN·7 granted patents·0 citations·filing 2016–2021
Top patents by PatentIndex Score
7 records- 0166US11834516B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2021·Granted Dec 5, 2023·0 cites·6 claims
- 0260US11142547B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 0356US12453774B2Tumor immunotherapy polypeptide and application thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Oct 28, 2025·0 cites·15 claims
- 0456US11213563B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Jan 4, 2022·0 cites·15 claims
- 0553US11161874B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Nov 2, 2021·0 cites·2 claims
- 0650US11612643B2Col14A1-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Mar 28, 2023·0 cites·8 claims
- 0742US11548925B2CACNA1H-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Jan 10, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when GENOIMMUNE THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →